Thus, it can be concluded that MTDH expressions in breast cancer cells are different due to different molecular phenotypes, and the overexpression of MTDH may be associated with the invasiveness and drug resistance of breast cancer cells. The gene discussed is MTDH; the disease is breast carcinoma.